An inhaled, widely available, asthma drugBritish patients will be able to access the first ever at-home Covid-19 treatment after theThe drug will be approved on a ‘case-by-case’ basis among older adults in the community, which means that GPs will be able to prescribe it to their patients.
Experts suggest that medical practitioners around the world may wish to consider the results of the study when making treatment decisions. For the interim report, a total of 961 patients were randomly assigned to receive inhaled budesonide at home.Of these, 751 people in the budesonide group and 1,028 in the usual care group had the virus and were included in the primary interim analysis.
Researchers say that since fewer people than expected were admitted to hospital in the trial, and with cases and admissions to hospital continuing to drop in the UK, the interim analysis – published as a pre-print – cannot suggest whether budesonide reduces hospital admissions.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.